Diabetes

Latest News

April 12th 2013
Measuring the Value of Better Diabetes Management

April 11th 2013

The Controversial Question of Metabolic Syndrome

April 11th 2013

Is There a Business Case for Diabetes Disease Management?

April 11th 2013

Targeting Insulin Resistance: The Ongoing Paradigm Shift in Diabetes Prevention

April 9th 2013

Episode 25 - Closing Remarks

CME Content

View More
Innovations in Medicine: 2024 Lineup of New and Approved Specialty Drugs
Online Article

Innovations in Medicine: 2024 Lineup of New and Approved Specialty Drugs

2.0 Credits / General Pharmacy

View more
Revolutionizing Acute Pain Relief: Emerging Nonopioid Therapies and the Essential Role of Managed Care
AJMC Supplement

Revolutionizing Acute Pain Relief: Emerging Nonopioid Therapies and the Essential Role of Managed Care

2.0 Credits / Pain Management

View more

Effectiveness and Cost-Effectiveness of Diabetes Prevention Among Adherent Participants

ByWilliam H. Herman, MD, MPH,Sharon L. Edelstein, ScM,Robert E. Ratner, MD,Maria G. Montez, RN, MSHP,Ronald T. Ackermann, MD, MPH,Trevor J. Orchard, MD,Mary A. Foulkes, PhD,Ping Zhang, PhD,Christopher D. Saudek, MD&dagger,Morton B. Brown, PhD,The Diabetes Prevention Program Research Group

Over 10 years, among adherent participants, lifestyle intervention and metformin were effective and cost-effective for diabetes prevention compared with placebo.
Brand Logo

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

609-716-7777

© 2025 MJH Life Sciences®

All rights reserved.

Secondary Brand Logo
Alt TextAlt Text